Frontiers in Cardiovascular Medicine

NOVEMBER 11, 2024

AimTo evaluate the real-life effectiveness and safety of hydrogen inhalation (HI) therapy as an additional treatment in Chinese adults with hypertension.MethodsThis observational, retrospective clinical study included hypertensive patients receiving routine antihypertensives with or without HI initiation from 2018 to 2023.

Hypertension 59

Hypertension Blood Pressure Research Outcomes 59

Frontiers in Cardiovascular Medicine

JULY 24, 2024

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.

Pulmonary 98

Pulmonary Hypertension Angioplasty Pharmacology 98

Circulation

APRIL 10, 2025

The purpose of this American Heart Association science advisory is to describe the existing evidence on device-measured sedentary behavior and light-intensity physical activity in relation to cardiovascular health during pregnancy and to make specific calls to action for future research to improve health outcomes and to promote health equity.

Blood Pressure 83

Blood Pressure Cardiovascular Disease Outcomes Hypertension 83

NEJM Journal Watch - Cardiology

JANUARY 8, 2025

In a secondary analysis from a randomized trial, no important differences were noted.

Hypertension 81

Hypertension Outcomes 81

Hypertension Journal

JANUARY 11, 2024

Hypertension, Ahead of Print. Although orthostatic hypotension (OH) has long been recognized as a manifestation of autonomic dysfunction, a growing body of literature has identified OH as a common comorbidity of hypertension. These strategies include countermaneuvers and short-acting vasoactive agents (midodrine, droxidopa).

Hypertension 81

Hypertension Blood Pressure Pharmacology Research 81

HCPLive

OCTOBER 4, 2024

An EADV 2024 study suggests dupilumab use during pregnancy is generally safe and may lower risks of preterm labor, gestational hypertension, and diabetes.

Diabetes 110

Diabetes Hypertension Outcomes 110

Frontiers in Cardiovascular Medicine

MARCH 30, 2025

Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed. The independent risk factors for mortality included left ventricular ejection fraction (LVEF), pulmonary hypertension, and low-density lipoprotein (LDL) levels (P<0.05).

Risk Factors 52

Risk Factors Pediatrics Cardiomyopathy Pulmonary 52

DAIC

MAY 6, 2024

The primary outcome measure for the study is change in six-minute walk distance from Baseline to Week 12. Results of Tenax Therapeutics’ Phase 2 HELP study of levosimendan in patients with pulmonary hypertension (PH) with heart failure with preserved ejection fraction (HFpEF) demonstrated that I.V.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension 105

Frontiers in Cardiovascular Medicine

APRIL 6, 2025

Despite advances in surgical and percutaneous interventions, hypertension remains a significant complication in AoC patients, even after successful repair. Chronic hypertension develops in 20%70% of patients and is a leading cause of long-term cardiovascular morbidity.

Hypertension 52

Hypertension Aortic ACE Inhibitor Congenital 52

Med Page Today

APRIL 1, 2025

(MedPage Today) -- CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients helped delay serious outcomes in the ZENITH trial. Among 172 patients, the drug reduced the.

Pulmonary 59

Pulmonary Hypertension Outcomes 59

American College of Cardiology

JUNE 12, 2024

Eagle looks at excess apolipoprotein-B and cardiovascular risk, then examines a recent meta-analysis on treating pulmonary arterial hypertension. Finally, Dr. Eagle shares some thoughts on a SMART-C collaborative meta-analysis of sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes.

Pulmonary 54

Pulmonary Hypertension Outcomes Article 54

Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

If pulmonary hypertension is additionally involved with vasoplegic syndrome, circulation management becomes much more complicated. The aim of this study is to investigate whether pituitrin is beneficial for the postoperative outcomes in patients with pulmonary hypertension undergoing cardiac surgery.

Pulmonary 59

Pulmonary Hypertension Outcomes Circulation 59

American College of Cardiology

DECEMBER 20, 2024

Is chlorthalidone superior to hydrochlorothiazide in preventing kidney outcomes when used for hypertension treatment?

Outcomes 65

Outcomes Hypertension Article 65

DAIC

JANUARY 8, 2025

a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. We believe suppression of aldosterone production by lorundrostat has the potential to reduce the nocturnal hypertension driving adverse cardiovascular outcomes.

Blood Pressure 52

Blood Pressure Hypertension Kidney Disease BMI 52

Hypertension Journal

APRIL 2, 2025

Hypertension, Ahead of Print. Blood pressure (BP) trajectories 20 weeks gestation predict HDP outcomes. Adjusted hazard ratios were higher among preeclampsia and gestational hypertension groups than for no HDP. for gestational hypertension, and 2.92 for gestational hypertension, and 2.92 for preeclampsia, 4.20

Blood Pressure 51

Blood Pressure Hypertension Cardiovascular Disease Outpatient 51

Journal of the American Heart Association

FEBRUARY 3, 2025

BackgroundDespite the poor outcomes related to the presence of pulmonary hypertension, it often goes undiagnosed in part because of low suspicion and screening tools not being easily accessible such as echocardiography. Journal of the American Heart Association, Ahead of Print.

Pulmonary 68

Pulmonary Hypertension Echocardiogram Physiology 68

Frontiers in Cardiovascular Medicine

APRIL 3, 2025

Complex cases included patients with large defects (25mm), multiple or fenestrated ASDs, deficient posterior-inferior rim <3mm, deficient retro-aortic rim <5mm, pulmonary hypertension, septal malalignment, and pregnancy. IntroductionZero-fluoroscopy, exclusively ultrasound-guided atrial septal defect (ASD) catheter closure has been reported.

Ultrasound 52

Ultrasound Pulmonary Hypertension Aortic 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Background Hypertension has now developed into a major public health problem worldwide. Objective This study aimed to systematically evaluate the effect of acupuncture alone or in combination with antihypertensive drugs on the efficiency of reducing blood pressure and controlling blood pressure in elderly patients with hypertension.

Hypertension 64

Hypertension Blood Pressure Public Health Pharmacology 64

American College of Cardiology

DECEMBER 14, 2023

What is the impact on prognosis of the 2022 ESC/ERS pulmonary hypertension (PH) guidelines on the new redefined hemodynamic threshold for the diagnosis of precapillary PH?

Pulmonary 46

Pulmonary Hypertension Outcomes Article 46

Becker's Hospital Review - Cardiology

FEBRUARY 12, 2024

The Association of Black Cardiologists is recruiting clinicians for a new certification program it launched in December related to hypertension management. The aim is to increase culturally conscious care for patient populations that are more likely to be diagnosed with the condition and experience adverse outcomes from it.

Certification 59

Certification Hypertension Outcomes 59

Open Heart

JUNE 6, 2023

Objective Pulmonary hypertension (PHT) commonly coexists with significant mitral regurgitation (MR), but its prevalence and prognostic importance have not been well characterised. In a large cohort of adults with moderate or greater MR, we aimed to describe the prevalence and severity of PHT and assess its influence on outcomes.

Bicuspid/Mitral 52

Bicuspid/Mitral Pulmonary Hypertension Outcomes 52

Open Heart

AUGUST 30, 2024

Objective To describe the impact of the pandemic on blood pressure screening and hypertension management based on a national quality of care scheme (Quality and Outcomes Framework, QOF) across key demographic, regional and clinical subgroups. Recorded hypertension prevalence was relatively stable at 15% throughout the study period.

COVID-19 52

COVID-19 Blood Pressure Hypertension Outcomes 52

Cardiometabolic Health Congress

SEPTEMBER 20, 2024

Hypertension is a condition that requires continuous monitoring, making it an ideal candidate for telehealth and digital health innovations. Why Telehealth is Essential for Hypertension For patients with hypertension, managing blood pressure outside of the office is crucial. Who Should Use Video Visits?

Blood Pressure 52

Blood Pressure Hypertension Lipid disorders Technology 52

Stroke Journal

DECEMBER 8, 2023

BACKGROUND:Therapeutic-induced hypertension treatment (iHTN) is helpful for alleviating early neurological deterioration (END) in acute small vessel occlusive stroke. Stroke, Ahead of Print.

Hypertension 75

Hypertension Stroke Strokes Risk Factors 75

Open Heart

APRIL 2, 2024

To maximie decision-making, facilitate effective patient counselling, and ultimately improve maternal and fetal outcomes as a whole, it is critical to comprehend the outcomes of SSP in women who have previously experienced PPCM. This study aimed to evaluate the outcomes of SSP in women with PPCM. to –4.09; p=0.004).

Cardiomyopathy 72

Cardiomyopathy Outcomes Hypertension 72

CardiacWire

JANUARY 29, 2025

Bioprosthetic patients also had higher rates of hypertension (78.7% The studys design also wasnt powered to make any certain conclusions due to its reliance on registry data, meaning a randomized head-to-head trial would be needed to confirm these outcomes. vs 71.8%) or prior PCI (6.7

BMI 80

BMI Aortic Hypertension Research 80

HCPLive

FEBRUARY 19, 2024

Patients receiving a nursing intervention had significantly better response rates, improvements in anxiety and depression scores, and significantly higher patient satisfaction when compared with the conventional care group.

Nursing 64

Nursing Hypertension Outcomes 64

Open Heart

MAY 7, 2024

Background The treatment of pulmonary hypertension (PH) has improved rapidly in recent decades. There is increasing evidence to support the role of early intervention and treatment in affecting clinical outcomes in PH. Specifically, changes in heart rate variability (HRV), heart rate (HR) and physical activity were assessed.

Heart Monitor 52

Heart Monitor Pulmonary Hypertension Angioplasty 52

Journal of the American Heart Association

JANUARY 10, 2025

BackgroundHypertension control and related cardiovascular outcomes among Americans remain suboptimal, and differ by race, ethnicity, and geography. Healthcare access is one of multiple critical factors in hypertension control. We created choropleth maps of hypertension control rates and assessed spatial autocorrelation.

Hypertension 45

Hypertension Outcomes 45

Heart BMJ

MARCH 13, 2025

The tricuspid valve (TV), historically deemed the ’forgotten valve’, is undergoing a renaissance as mounting evidence highlights its critical role in cardiovascular outcomes. TR: the clinical burden and the need for recalibration TR has been underestimated in its impact on morbidity and mortality. 2 3 Furthermore, persistent.

Tricuspid 52

Tricuspid Pulmonary Article Heart Disease 52

CardiacWire

APRIL 9, 2025

Evaluating the ACO incentives , researchers compared care quality data from the ACCs NCDR PINNACLE Registry before and 6-12 months after MSSP participation at 83 ACO outpatient cardiology practices versus 332 non-ACO practices and found MSSP ACO participation made no difference in coronary artery disease, HF, AFib, or hypertension outcomes.

Medicare 59

Medicare Outpatient Coronary Artery Disease AFIB 59

Heart BMJ

MARCH 26, 2025

2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes. Common predictors include older age, prior hypertension, diabetes and atrial fibrillation. Risk factors for developing HF after MI vary and are influenced by whether the patient has HFrEF or HFpEF.

Myocardial Infarction 52

Myocardial Infarction Preserved Ejection Fraction Heart Failure Aortic valve 52

Hypertension Journal

MARCH 31, 2025

Hypertension, Ahead of Print. BACKGROUND:Primary aldosteronism (PA) is a distinct cause of low-renin hypertension (LRH), characterized by inappropriate aldosterone production.

Hypertension 40

Hypertension Physiology Outcomes 40

DAIC

MARCH 10, 2025

Yasser Sammour, MD, MScpresented "Long-Term Hemodynamic Performance and Clinical Outcomes in Small and Large Aortic Annuli Patients with Severe Aortic Stenosis."This The association of BVD with clinical outcomes (unadjusted for covariates) was evaluated by small and large annuli (CT annular diameter 23 vs >23 mm).

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

Journal of the American Heart Association

APRIL 10, 2025

BackgroundNarcolepsy is linked to adverse cardiovascular disease (CVD) outcomes, but few studies have examined its associations with subclinical CVD, including in children. Detection of these outcomes early in the course of narcolepsy could help reduce the burden of adverse cardiovascular events later in life.

Cardiovascular Disease 76

Cardiovascular Disease Diabetes Hypertension Medicare 76

Med Page Today

MAY 16, 2024

(MedPage Today) -- Bringing blood pressure under control in the ambulance didn't improve stroke outcomes in an unselected population, the China-based INTERACT 4 trial showed. Functional outcome measured by the modified Rankin Scale was no better.

Blood Pressure 59

Blood Pressure Stroke Strokes Hypertension 59

Frontiers in Cardiovascular Medicine

MAY 14, 2024

BackgroundTriglyceride-glucose (TyG) index and hypertension were well-established risk factors for stroke. And TyG index was associated with hypertension. However, no prior study has investigated the interactive effects of the TyG index and hypertension on stroke. 3.48; Synergy index: 4.13, 95% CI, 2.73–6.25).

Hypertension 52

Hypertension Stroke Strokes Risk Factors 52